Cargando…

Background Parenchymal Enhancement of the Contralateral Normal Breast: Association with Tumor Response in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy()

PURPOSE: This study investigated the association between background parenchymal enhancement (BPE) and pathologic response to neoadjuvant chemotherapy (NAC). METHODS: A total of 46 patients diagnosed with invasive breast cancer were analyzed. Each patient had three magnetic resonance imaging (MRI) st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jeon Hor, Yu, Hon J., Hsu, Christine, Mehta, Rita S., Carpenter, Philip M., Su, Min Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487259/ https://www.ncbi.nlm.nih.gov/pubmed/26055178 http://dx.doi.org/10.1016/j.tranon.2015.04.001

Ejemplares similares

Quantitative background parenchymal enhancement to predict recurrence after neoadjuvant chemotherapy for breast cancer
por: Moliere, Sebastien, et al.
Publicado: (2019)

The correlation of background parenchymal enhancement in the contralateral breast with patient and tumor characteristics of MRI-screen detected breast cancers
por: Vreemann, Suzan, et al.
Publicado: (2018)

Clinical Application of Magnetic Resonance Imaging in Management of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
por: Chen, Jeon-Hor, et al.
Publicado: (2013)

Association Between Background Parenchymal Enhancement and Pathologic Complete Remission Throughout the Neoadjuvant Chemotherapy in Breast Cancer Patients
por: You, Chao, et al.
Publicado: (2017)

Background parenchymal enhancement: behavior during neoadjuvant chemotherapy for breast cancer and relationship with a pathological complete response
por: Teixeira, Sandra Regina Campos, et al.
Publicado: (2020)

Erratum to: Magnetic Resonance Imaging Evaluation of Noninflammatory Breast Cancer with Skin Involvement After Neoadjuvant Chemotherapy
por: Chen, Jeon-Hor, et al.
Publicado: (2010)

Background parenchymal enhancement in preoperative breast MRI
por: Kohara, Satoko, et al.
Publicado: (2015)

Analysis of background parenchymal echogenicity on breast ultrasound: Correlation with mammographic breast density and background parenchymal enhancement on magnetic resonance imaging
por: Ko, Kyung Hee, et al.
Publicado: (2017)

Contralateral parenchymal enhancement on breast MRI before and during neoadjuvant endocrine therapy in relation to the preoperative endocrine prognostic index
por: Ragusi, Max A. A., et al.
Publicado: (2020)

Background Parenchymal Enhancement on Preoperative Magnetic Resonance Imaging: Association With Recurrence-Free Survival in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy
por: Choi, Ji Soo, et al.
Publicado: (2016)

Changes in background parenchymal enhancement in HER2-positive breast cancer before and after neoadjuvant chemotherapy: Association with pathologic complete response
por: Dong, Jing-Min, et al.
Publicado: (2018)

MRI Texture Analysis of Background Parenchymal Enhancement of the Breast
por: Amano, Yasuo, et al.
Publicado: (2017)

MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer
por: Bennani-Baiti, Barbara, et al.
Publicado: (2016)

Response Predictivity to Neoadjuvant Therapies in Breast Cancer: A Qualitative Analysis of Background Parenchymal Enhancement in DCE-MRI
por: La Forgia, Daniele, et al.
Publicado: (2021)

Correction: MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer
por: Bennani-Baiti, Barbara, et al.
Publicado: (2016)

Fibroglandular Tissue and Background Parenchymal Enhancement on Breast MR Imaging Correlates With Breast Cancer
por: Hu, Xiaoxin, et al.
Publicado: (2021)

Magnetic Resonance Imaging Evaluation of Noninflammatory Breast Cancer with Skin Involvement After Neoadjuvant Chemotherapy
por: Chen, Jeon-Hor, et al.
Publicado: (2010)

Effects of neoadjuvant chemotherapy on the contralateral non-tumor-bearing breast assessed by diffuse optical tomography
por: Altoe, Mirella L., et al.
Publicado: (2021)

Breast cancer and background parenchymal enhancement at breast magnetic resonance imaging: a meta-analysis
por: Hu, Na, et al.
Publicado: (2021)

MRI background parenchymal enhancement, breast density and serum hormones in postmenopausal women
por: Brooks, Jennifer D., et al.
Publicado: (2018)

Changes in mammographically normal contralateral breast in cases of breast carcinoma.
por: Prasad, A., et al.
Publicado: (1989)

Quantitative assessment of background parenchymal enhancement in breast magnetic resonance images predicts the risk of breast cancer
por: Hu, Xiaoxin, et al.
Publicado: (2016)

Postmastectomy Radiotherapy for Locally Advanced Breast Cancer Receiving Neoadjuvant Chemotherapy
por: Meattini, Icro, et al.
Publicado: (2014)

Comparison of Segmentation Methods in Assessing Background Parenchymal Enhancement as a Biomarker for Response to Neoadjuvant Therapy
por: Nguyen, Alex Anh-Tu, et al.
Publicado: (2020)

Association of breast cancer with MRI background parenchymal enhancement: the IMAGINE case-control study
por: Watt, Gordon P., et al.
Publicado: (2020)

Quantitative background parenchymal uptake on molecular breast imaging and breast cancer risk: a case-control study
por: Hruska, Carrie B., et al.
Publicado: (2018)

Background Parenchymal Enhancement on Breast MRI as a Prognostic Surrogate: Correlation With Breast Cancer Oncotype Dx Score
por: Zhang, Michelle, et al.
Publicado: (2021)

The association between breast cancer risk factors and background parenchymal enhancement at dynamic contrast-enhanced breast MRI
por: Hellgren, Roxanna, et al.
Publicado: (2020)

Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy
por: Cao, Maria D, et al.
Publicado: (2012)

Tumor infiltrating lymphocytes in triple negative breast cancer receiving neoadjuvant chemotherapy
por: Castaneda, Carlos A, et al.
Publicado: (2016)

Prediction of background parenchymal enhancement on breast MRI using mammography, ultrasonography, and diffusion-weighted imaging
por: Kawamura, Akiko, et al.
Publicado: (2015)

Prophylactic breast irradiation reduces background parenchymal enhancement (BPE) on MRI: A secondary analysis()
por: Ben-David, Merav A., et al.
Publicado: (2019)

Quantitative background parenchymal enhancement and fibro-glandular density at breast MRI: Association with BRCA status
por: Goodburn, Rosie, et al.
Publicado: (2023)

Background parenchymal uptake on molecular breast imaging as a breast cancer risk factor: a case-control study
por: Hruska, Carrie B., et al.
Publicado: (2016)

Using MRI to plan breast-conserving surgery following neoadjuvant chemotherapy for early breast cancer
por: Bhattacharyya, M, et al.
Publicado: (2008)

Microarray-based comparative genomic hybridisation of breast cancer patients receiving neoadjuvant chemotherapy
por: Pierga, J-Y, et al.
Publicado: (2007)

Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
por: Fasching, Peter A, et al.
Publicado: (2011)

Predictive and prognostic value of EPIC1 in patients with breast cancer receiving neoadjuvant chemotherapy
por: Xu, Yaqian, et al.
Publicado: (2020)

Characterization of circulating tumor cells in early breast cancer patients receiving neoadjuvant chemotherapy
por: Jakabova, Anna, et al.
Publicado: (2021)

Plasma Proteome Signature to Predict the Outcome of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
por: Gwark, Sungchan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vsuebkokkimnkgs25uo7ghsfl1